Bank of Nova Scotia’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.55M | Sell |
16,446
-3,990
| -20% | -$763K | 0.01% | 684 |
|
|
2026
Q1 | $3.75M | Sell |
20,436
-2,259
| -10% | -$416K | 0.01% | 638 |
|
|
2025
Q4 | $3.99M | Sell |
22,695
-1,656
| -7% | -$271K | 0.01% | 679 |
|
|
2025
Q3 | $3.41M | Buy |
24,351
+8,017
| +49% | +$1.08M | 0.01% | 615 |
|
|
2025
Q2 | $2.05M | Buy |
16,334
+23
| +0.1% | +$2.87K | ﹤0.01% | 678 |
|
|
2025
Q1 | $2.23M | Sell |
16,311
-4,241
| -21% | -$606K | 0.01% | 598 |
|
|
2024
Q4 | $3.14M | Buy |
20,552
+1,915
| +10% | +$323K | 0.01% | 612 |
|
|
2024
Q3 | $3.61M | Buy |
18,637
+3,485
| +23% | +$729K | 0.01% | 529 |
|
|
2024
Q2 | $3.51M | Sell |
15,152
-87,907
| -85% | -$19.1M | 0.01% | 531 |
|
|
2024
Q1 | $22.2M | Sell |
103,059
-57,204
| -36% | -$13.4M | 0.04% | 254 |
|
|
2023
Q4 | $41.5M | Buy |
160,263
+130,169
| +433% | +$32M | 0.08% | 181 |
|
|
2023
Q3 | $7.73M | Buy |
30,094
+17,036
| +130% | +$4.56M | 0.02% | 353 |
|
|
2023
Q2 | $3.72M | Buy |
13,058
+1,742
| +15% | +$519K | 0.01% | 416 |
|
|
2023
Q1 | $3.15M | Sell |
11,316
-1,924
| -15% | -$532K | 0.01% | 454 |
|
|
2022
Q4 | $3.67M | Buy |
13,240
+1,248
| +10% | +$352K | 0.01% | 523 |
|
|
2022
Q3 | $3.2M | Sell |
11,992
-105
| -0.9% | -$22.3K | 0.01% | 521 |
|
|
2022
Q2 | $2.47M | Sell |
12,097
-6,157
| -34% | -$1.26M | 0.01% | 643 |
|
|
2022
Q1 | $3.84M | Sell |
18,254
-13,333
| -42% | -$2.9M | 0.01% | 653 |
|
|
2021
Q4 | $7.58M | Buy |
31,587
+7,281
| +30% | +$1.87M | 0.01% | 606 |
|
|
2021
Q3 | $6.88M | Buy |
24,306
+1,684
| +7% | +$552K | 0.01% | 562 |
|
|
2021
Q2 | $7.83M | Sell |
22,622
-5,834
| -21% | -$1.77M | 0.01% | 495 |
|
|
2021
Q1 | $7.96M | Buy |
28,456
+2,617
| +10% | +$706K | 0.02% | 456 |
|
|
2020
Q4 | $6.33M | Buy |
25,839
+4,910
| +23% | +$1.27M | 0.01% | 451 |
|
|
2020
Q3 | $5.94M | Sell |
20,929
-62,336
| -75% | -$17.4M | 0.02% | 440 |
|
|
2020
Q2 | $22.3M | Buy |
83,265
+36,660
| +79% | +$11M | 0.08% | 201 |
|
|
2020
Q1 | $14.7M | Sell |
46,605
-349,482
| -88% | -$106M | 0.05% | 255 |
|
|
2019
Q4 | $118M | Buy |
396,087
+194,710
| +97% | +$54M | 0.29% | 86 |
|
|
2019
Q3 | $46.9M | Buy |
201,377
+80,214
| +66% | +$18.7M | 0.14% | 142 |
|
|
2019
Q2 | $28.3M | Sell |
121,163
-259
| -0.2% | -$59.8K | 0.12% | 174 |
|
|
2019
Q1 | $28.7M | Buy |
121,422
+59,511
| +96% | +$18.7M | 0.11% | 184 |
|
|
2018
Q4 | $18.6M | Buy |
61,911
+18,698
| +43% | +$5.97M | 0.09% | 197 |
|
|
2018
Q3 | $15.3M | Buy |
43,213
+18,926
| +78% | +$6.52M | 0.07% | 236 |
|
|
2018
Q2 | $7.05M | Sell |
24,287
-4,495
| -16% | -$1.26M | 0.04% | 302 |
|
|
2018
Q1 | $7.88M | Sell |
28,782
-5,121
| -15% | -$1.59M | 0.04% | 320 |
|
|
2017
Q4 | $10.8M | Sell |
33,903
-4,315
| -11% | -$1.38M | 0.05% | 300 |
|
|
2017
Q3 | $12M | Sell |
38,218
-10,027
| -21% | -$2.97M | 0.07% | 232 |
|
|
2017
Q2 | $13.1M | Sell |
48,245
-1,204
| -2% | -$318K | 0.07% | 245 |
|
|
2017
Q1 | $13.5M | Buy |
49,449
+44,576
| +915% | +$12.6M | 0.06% | 240 |
|
|
2016
Q4 | $1.38M | Buy |
4,873
+420
| +9% | +$124K | 0.01% | 436 |
|
|
2016
Q3 | $1.39M | Buy |
4,453
+80
| +2% | +$23.7K | 0.01% | 354 |
|
|
2016
Q2 | $1.06M | Buy |
4,373
+210
| +5% | +$55.3K | 0.01% | 359 |
|
|
2016
Q1 | $1.08M | Sell |
4,163
-3
| -0.1% | -$792 | 0.01% | 355 |
|
|
2015
Q4 | $1.28M | Sell |
4,166
-218
| -5% | -$62.6K | 0.01% | 374 |
|
|
2015
Q3 | $1.28M | Sell |
4,384
-34,840
| -89% | -$11.5M | 0.01% | 300 |
|
|
2015
Q2 | $15.8M | Buy |
39,224
+35,186
| +871% | +$14.1M | 0.08% | 119 |
|
|
2015
Q1 | $1.71M | Sell |
4,038
-49,934
| -93% | -$19.7M | 0.01% | 239 |
|
|
2014
Q4 | $18.3M | Buy |
53,972
+50,032
| +1,270% | +$16.2M | 0.07% | 123 |
|
|
2014
Q3 | $1.3M | Buy |
3,940
+150
| +4% | +$49.5K | 0.01% | 259 |
|
|
2014
Q2 | $1.2M | Buy |
3,790
+253
| +7% | +$76.1K | ﹤0.01% | 268 |
|
|
2014
Q1 | $1.08M | Buy |
3,537
+211
| +6% | +$67K | ﹤0.01% | 296 |
|
|
2013
Q4 | $930K | Buy |
3,326
+141
| +4% | +$36.5K | ﹤0.01% | 323 |
|
|
2013
Q3 | $767K | Sell |
3,185
-160,115
| -98% | -$35.8M | ﹤0.01% | 295 |
|
|
2013
Q2 | $35.1M | Buy |
+163,300
| New | +$34.9M | 0.18% | 71 |
|
Other funds holding BIIB
Bank of Nova Scotia's BIIB Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Biogen (BIIB) stake by 20% in Q2 2026, selling an estimated $763K and leaving 16,446 shares worth $3.55M. The position accounts for 0.01% of the portfolio, ranked #684.
Bank of Nova Scotia first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q4 2019. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Bank of Nova Scotia held 16,446 shares of Biogen worth $3.55M as of Q2 2026.
- Bank of Nova Scotia sold 3,990 Biogen shares in Q2 2026, an estimated $763K.
- Biogen made up 0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #684 holding.
- Bank of Nova Scotia first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Bank of Nova Scotia's Biogen position peaked at $118M in Q4 2019.
- 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.